HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anticancer and antimetastatic activities of Renieramycin M, a marine tetrahydroisoquinoline alkaloid, in human non-small cell lung cancer cells.

AbstractBACKGROUND:
Renieramycin M, has been shown to exhibit promising anticancer activity against some cancer cell lines; however, the underlying mechanism remains unknown.
MATERIALS AND METHODS:
Renieramycin M was isolated from the blue sponge Xestospongia sp. Anticancer and antimetastatic activities of renieramycin M were investigated in human non-small cell lung cancer cells.
RESULTS:
Renieramycin M treatment caused p53 activation, which subsequently down-regulated anti-apoptotic MCL-1 and BCL-2 proteins, while the level of pro-apoptotic BAX protein was not altered. The subtoxic concentrations of renieramycin M significantly decreased invasion and migration abilities of cancer cells. In addition, this compound showed a strong inhibitory effect on anchorage-independent growth of the cells.
CONCLUSION:
These results reveal that renieramycin M induced lung cancer cells apoptosis through p53-dependent pathway and the compound may inhibit progression and metastasis of lung cancer cells.
AuthorsHasseri Halim, Preedakorn Chunhacha, Khanit Suwanborirux, Pithi Chanvorachote
JournalAnticancer research (Anticancer Res) Vol. 31 Issue 1 Pg. 193-201 (Jan 2011) ISSN: 1791-7530 [Electronic] Greece
PMID21273598 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Alkaloids
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Proto-Oncogene Proteins c-bcl-2
  • TP53 protein, human
  • Tetrahydroisoquinolines
  • Tumor Suppressor Protein p53
  • renieramycin M
Topics
  • Alkaloids (pharmacology)
  • Animals
  • Anoikis (drug effects)
  • Apoptosis (drug effects)
  • Blotting, Western
  • Carcinoma, Non-Small-Cell Lung (drug therapy, metabolism, pathology)
  • Cell Adhesion (drug effects)
  • Cell Movement (drug effects)
  • Cell Proliferation (drug effects)
  • Colony-Forming Units Assay
  • Humans
  • Lung Neoplasms (drug therapy, metabolism, pathology)
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Porifera (chemistry)
  • Proto-Oncogene Proteins c-bcl-2 (metabolism)
  • Tetrahydroisoquinolines (pharmacology)
  • Tumor Cells, Cultured
  • Tumor Suppressor Protein p53 (metabolism)
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: